Attorney General Aaron M. Frey announced a settlement agreement with Sanofi-Aventis U.S. LLC after scrutiny over the ...
California dedicated $100 to manufacturing insulin for diabetic residents. That effort is taking longer than Gov. Gavin ...
Semglee has been approved for over a year as a regular biosimilar to Lantus (insulin glargine), meaning that it could be used in place of Sanofi's drug, but only if specifically prescribed for a ...
A SoloStar™ prefilled (disposable) pen containing 3 mL of 100 units/mL insulin glargine and 33 μg/mL lixisenatide 3:1 ratio permitting a dose range of 15 units/5μg to 60units/20μg was used to ...
Merilog 100units/mL is supplied as both a 10mL multi-dose vial as well as a 3mL single-patient-use prefilled pen. The Food and Drug Administration (FDA) has approved Merilog (insulin-aspart-szjj), a ...
These pens handle notes and can transform them into digital images, record audio, and edit pre-existing notes. Like the Livescribe Symphony Smartpen, which does all of those useful things ...
While long-acting insulin is slow to reach the bloodstream and has a relatively low peak, it stabilizes the “plateau” effect on blood sugar that can last most of the day. Glargine or Lantus is ...
The Global Smart Insulin Pens Market was valued USD 102.86 Million in 2022 and is anticipated to reach a value of USD 251.06 Million by 2030. In the projection period, the Global Market is forecasted ...
The US Food and Drug Administration has approved Merilog (insulin-aspart-szjj) as a biosimilar to Novolog ... Both a 3-mL single-patient-use prefilled pen and a 10-mL multiple-dose vial are included ...
Initially limited to insulin glargine, etanercept and infliximab, this Initiative was later expanded to rituximab, adalimumab and insulin lispro/aspart. If a biologic-experienced patient wishes to ...
Food that can support insulin sensitivity include non-starchy vegetables, whole grains, and citrus fruits. People with insulin resistance may also wish to limit sugary drinks and highly processed ...